Iosat 130 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DR26FGGR8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,613
Award facts
- Contract value 100% obligated
- $1,612.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $1,612.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on June 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for IOSAT 130 MG tablets (14-count packaging). Ultimate completion date is June 15, 2026. Place of performance is Park Ridge, IL. The order carries firm fixed-price pricing with no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26FGGR8?
SPE2DR26FGGR8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 12, 2026.
How much is contract SPE2DR26FGGR8 worth?
The government has obligated $1,613 on SPE2DR26FGGR8.
Is contract SPE2DR26FGGR8 an order under another contract?
Yes. SPE2DR26FGGR8 is a delivery order under SPE2DR25D9349, an indefinite delivery contract.
Was contract SPE2DR26FGGR8 competed?
The extent of competition for SPE2DR26FGGR8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award